These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 437449)

  • 1. Ascites in cirrhosis of the liver.
    Buhac I
    Gastroenterology; 1979 Jun; 76(6):1503. PubMed ID: 437449
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of sodium retention in early cirrhosis of the liver: evidence for vascular overfilling.
    Levy M
    Semin Liver Dis; 1994 Feb; 14(1):4-13. PubMed ID: 8016661
    [No Abstract]   [Full Text] [Related]  

  • 3. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
    Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
    Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compartmentalization of ascites and edema in patients with hepatic cirrhosis.
    Shear L; Ching S; Gabuzda GJ
    N Engl J Med; 1970 Jun; 282(25):1391-6. PubMed ID: 4910836
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dynamics of ascitic fluid in decompensated cirrhosis].
    Milani A; Mazzone M; Rossi L
    Recenti Prog Med; 1999 Feb; 90(2):94-9. PubMed ID: 10208100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood.
    Nguyen-Khac E; Thevenot T; Capron D; Dharancy S; Paupart T; Thabut D; Tiry C
    Eur J Intern Med; 2008 Dec; 19(8):613-8. PubMed ID: 19046728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical importance of determining aldosterone in the ascitic fluid].
    Maleeva A; Stanchev N; Konstantinova N; Aleksiev A
    Vutr Boles; 1990; 29(6):72-7. PubMed ID: 2091389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of ascites formation in rats with experimental cirrhosis.
    López-Novoa JM; Rengel MA; Hernando L
    Am J Physiol; 1980 May; 238(5):F353-7. PubMed ID: 7377346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolism and kinetics of ampicillin elimination in cirrhosis. Therapeutical consequences (author's transl)].
    Chalas J; Labayle D; Macarrio J; Barraud D; Lindenbaum A; Buffet C; Chaput JC
    Sem Hop; 1980 Mar 8-15; 56(9-10):464-9. PubMed ID: 6244668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium retention in cirrhosis and ascites: effects of continuous peritoneovenous shunting.
    Wexler MJ; Levy M
    Surg Forum; 1978; 29():473-4. PubMed ID: 401228
    [No Abstract]   [Full Text] [Related]  

  • 11. [Peritoneal diffusion of gentamicin in the ascitic cirrhotic].
    Bars L; Hecht Y; Beaugrand M; Ferrier JP; Hornstein M
    Nouv Presse Med; 1979 Feb; 8(8):614. PubMed ID: 461180
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevation of cytokines in peritoneal fluid and blood in patients with liver cirrhosis.
    Eriksson AS; Gretzer C; Wallerstedt S
    Hepatogastroenterology; 2004; 51(56):505-9. PubMed ID: 15086192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expressions of aquaporin-1 on peritonea in hepatic cirrhotic rats with ascites].
    Liang Q; Xu SR; Liu W; Deng LX; Sun DY
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1027-30. PubMed ID: 16029543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume of ascitic fluid.
    Leidner MH
    N Engl J Med; 1970 Oct; 283(18):1000. PubMed ID: 4919081
    [No Abstract]   [Full Text] [Related]  

  • 15. Bile acids in ascites of a case with liver cirrhosis.
    Harada M; Takahashi M; Kodama M; Ezaki H
    Hiroshima J Med Sci; 1983 Sep; 32(3):281-4. PubMed ID: 6315640
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathophysiology of ascites formation.
    Dudley FJ
    Gastroenterol Clin North Am; 1992 Mar; 21(1):215-35. PubMed ID: 1568774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin in the ascitic fluid of patients with liver cirrhosis.
    Cugno M; Salerno F; Nussberger J; Bottasso B; Lorenzano E; Agostoni A
    Clin Sci (Lond); 2001 Dec; 101(6):651-7. PubMed ID: 11724653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance.
    Tarao K; So K; Moroi T; Ikeuchi T; Suyama T
    Gastroenterology; 1977 Sep; 73(3):539-42. PubMed ID: 892353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of ascites on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Macias JG; Diez JL; Nieto MJ
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):57-61. PubMed ID: 7372376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of albumin synthesis in rat hepatocytes by ascites from patients with cirrhosis.
    Escobar E; Shimizu I; Mizobuchi Y; Yasuda M; Ito S
    Tokushima J Exp Med; 1996 Dec; 43(3-4):159-66. PubMed ID: 9100464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.